Chung‐Jen Chen
Impact in
- Strategy and Management top 1%
- Innovation and Knowledge Management
-
- Entrepreneurship Studies and Influences
Papers in
- Rheumatology 37
- Systemic Lupus Erythematosus Research 22
- Rheumatoid Arthritis Research and Therapies 10
- Nephrology 17
- Gout, Hyperuricemia, Uric Acid 17
- Co-authors
- Bou‐Wen LinYi‐Fen HuangHsueh‐Liang WuYung‐Chang HsiaoJeng‐Hsien YenHong‐Wen LiuShun‐Jen ChangIra Pastan
- Journals
- Journal of Business Research (6 papers)IEEE Transactions on Engineering Management (3 papers)International Journal of Molecular Sciences (3 papers)Technological Forecasting and Social Change (3 papers)R and D Management (3 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Chung‐Jen Chen
162 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 187
- Strategy and Management 973
- Management of Technology and Innovation 443
- Nephrology 310
- Rheumatology 567
- Business and International Management 69
Countries citing papers authored by Chung‐Jen Chen
This map shows the geographic impact of Chung‐Jen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Jen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Jen Chen more than expected).
Fields of papers citing papers by Chung‐Jen Chen
This network shows the impact of papers produced by Chung‐Jen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Jen Chen. The network helps show where Chung‐Jen Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chung‐Jen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 12 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 5 | |
| 6 | 2020 | 1 | |
| 7 | 2015 | 4 | |
| 8 | 2011 | 17 | |
| 9 | 2009 | 20 | |
| 10 | 2009 | 1 | |
| 11 | 2008 | 2 | |
| 12 | 2008 | 1 | |
| 13 | 2006 | 1 | |
| 14 | High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. | 2005 | 59 |
| 15 | 2004 | 1 | |
| 16 | 2004 | 30 | |
| 17 | 2002 | 61 | |
| 18 | 2001 | 7 | |
| 19 | 2001 | 6 | |
| 20 | 1994 | 5 |
About Chung‐Jen Chen
Chung‐Jen Chen is a scholar working on Rheumatology, Nephrology, Strategy and Management, Management of Technology and Innovation and Accounting, having authored 166 papers that have together received 4.3k indexed citations. Recurring topics across this work include Innovation and Knowledge Management (23 papers), Systemic Lupus Erythematosus Research (22 papers), Gout, Hyperuricemia, Uric Acid (17 papers), Corporate Finance and Governance (15 papers), Rheumatoid Arthritis Research and Therapies (10 papers), International Business and FDI (10 papers), Firm Innovation and Growth (10 papers) and Entrepreneurship Studies and Influences (9 papers). The work is most often cited by research in Strategy and Management (973 citations), Management of Technology and Innovation (443 citations), Nephrology (310 citations), Rheumatology (567 citations) and Business and International Management (69 citations). Chung‐Jen Chen has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Bou‐Wen Lin, Yi‐Fen Huang, Hsueh‐Liang Wu, Yung‐Chang Hsiao, Jeng‐Hsien Yen, Hong‐Wen Liu, Shun‐Jen Chang, Ira Pastan, Michael M. Gottesman and Igor B. Roninson. Their work appears in journals such as Journal of Business Research, IEEE Transactions on Engineering Management, International Journal of Molecular Sciences, Technological Forecasting and Social Change and R and D Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.